| Unique ID issued by UMIN | UMIN000047617 |
|---|---|
| Receipt number | R000046910 |
| Scientific Title | nvestigation on the pregnancy and postpartum flora of mothers drinking Bifidobacterium fermented milk and the microbiome of the newborn from birth to 2 years of age |
| Date of disclosure of the study information | 2022/04/28 |
| Last modified on | 2024/11/20 17:30:55 |
Effect of Bifidobacterium fermented milk on mother and infant microbiome: sequential observation of gut microbiota during pregnancy and the first two years for infants
Effect of Bifidobacterium fermented milk on mother and infant microbiota
nvestigation on the pregnancy and postpartum flora of mothers drinking Bifidobacterium fermented milk and the microbiome of the newborn from birth to 2 years of age
Effect of Bifidobacterium fermented milk on mother and infant microbiota
| Japan |
Healthy pregnant women and offspring
| Obstetrics and Gynecology |
Others
NO
The study aim to evaluate the relation of bifidobacteria fermented milk on microbiota of mother and infants in association with gastrointestinal symptoms and allergy.
Efficacy
Gut microbiome
mother: during pregnancy and after childbirth
infants: the first two years
Vaginal microbiome
Gastrointestinal symptoms
Intestinal environment (pH, organic acid)
Allergies of infant
mother: during pregnancy and after childbirth
infants: the first two years
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
| Food |
Bifidobacterium fermented milk
one bottle per day
from 28 weeks to 9 weeks after childbirth
| 20 | years-old | <= |
| Not applicable |
Male and Female
Japanese pregnant women who are undergoing prenatal checkups at the Research Center for Child Health and Development and are planning to have childbirth and postpartum checkups at this center
Pregnant woman who plan vaginal delivery
Singleton pregnancy
Pregnancy Over 20 years old
Pregnant women who understand the research contents, show consent, and can keep the research contents confidential
Pregnant woman with fetal morphological abnormalities
Pregnant women with hypertension, diabetes, autoimmune disease, etc.)
Pregnant women who will be treated with antibiotics at birth
Pregnant women who participate the other innervation (e.g. other functional foods, drugs or cosmetics) during this study period.
Pregnant women with milk or gelatin allergies
Pregnant women who is not appropriate to participated the study (as judged by the medical doctor)
40
| 1st name | Tomo Suzuki |
| Middle name | |
| Last name | Suzuki |
National Center for Child Health and Development
Center for Maternal-Fetal, Neonatal and Reproductive Medicine
157-8535
2-10-1 Okura, Setagaya-ku, Tokyo, Japan
03-3416-0181
suzuki-tm@ncchd.go.jp
| 1st name | Tomo Suzuki |
| Middle name | |
| Last name | Suzuki |
National Center for Child Health and Development
Center for Maternal-Fetal, Neonatal and Reproductive Medicine
157-8535
2-10-1 Okura, Setagaya-ku, Tokyo, Japan
03-3416-0181
suzuki-tm@ncchd.go.jp
National Center for Child Health and Development
Yakult Honsha Co., Ltd.
Profit organization
KSO Corporation
National Center for Child Health and Development
2-10-1 Okura, Setagaya-ku, Tokyo, Japan
03-3416-0181
suzuki-tm@ncchd.go.jp
NO
| 2022 | Year | 04 | Month | 28 | Day |
Unpublished
39
No longer recruiting
| 2020 | Year | 12 | Month | 10 | Day |
| 2020 | Year | 12 | Month | 10 | Day |
| 2022 | Year | 05 | Month | 01 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2022 | Year | 04 | Month | 28 | Day |
| 2024 | Year | 11 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000046910